SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $442,462 | -57.2% | 11,601 | -56.1% | 0.01% | -61.5% |
| Q3 2022 | $1,034,000 | +4.2% | 26,413 | -14.0% | 0.03% | 0.0% |
| Q2 2022 | $992,000 | -51.1% | 30,700 | -49.9% | 0.03% | -45.8% |
| Q1 2022 | $2,029,000 | -37.9% | 61,293 | +6.6% | 0.05% | -54.3% |
| Q2 2021 | $3,266,000 | +310.8% | 57,500 | +441.4% | 0.10% | +250.0% |
| Q1 2021 | $795,000 | +19.9% | 10,621 | +38.6% | 0.03% | +20.0% |
| Q4 2020 | $663,000 | -22.7% | 7,664 | -45.4% | 0.02% | -51.9% |
| Q3 2020 | $858,000 | -14.8% | 14,034 | -42.0% | 0.05% | -24.6% |
| Q2 2020 | $1,007,000 | +66.2% | 24,209 | +14.7% | 0.07% | +38.0% |
| Q1 2020 | $606,000 | -63.0% | 21,113 | -6.9% | 0.05% | -64.8% |
| Q4 2019 | $1,637,000 | +358.5% | 22,683 | +895.7% | 0.14% | +358.1% |
| Q2 2018 | $357,000 | -40.7% | 2,278 | -39.0% | 0.03% | -56.3% |
| Q1 2018 | $602,000 | -6.5% | 3,735 | -4.4% | 0.07% | -24.5% |
| Q4 2017 | $644,000 | – | 3,908 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |